Handelsbanken Fonder’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2M Buy
189,581
+122,100
+181% +$14.8M 0.06% 266
2026
Q1
$11M Buy
67,481
+3,900
+6% +$600K 0.04% 357
2025
Q4
$11.1M Buy
63,581
+13,400
+27% +$2.45M 0.03% 371
2025
Q3
$7.23M Buy
50,181
+2,100
+4% +$257K 0.02% 422
2025
Q2
$4.84M Sell
48,081
-1,100
-2% -$84.1K 0.02% 434
2025
Q1
$3.75M Buy
49,181
+3,900
+9% +$298K 0.02% 483
2024
Q4
$3.13M Buy
45,281
+1,700
+4% +$122K 0.01% 540
2024
Q3
$3.18M Buy
43,581
+8,800
+25% +$649K 0.01% 525
2024
Q2
$2.33M Buy
34,781
+4,300
+14% +$167K 0.01% 547
2024
Q1
$827K Buy
30,481
+1,900
+7% +$53.2K ﹤0.01% 926
2023
Q4
$886K Buy
28,581
+700
+3% +$18.2K ﹤0.01% 854
2023
Q3
$704K Hold
27,881
﹤0.01% 883
2023
Q2
$588K Sell
27,881
-1,500
-5% -$28.5K ﹤0.01% 982
2023
Q1
$501K Buy
29,381
+11,200
+62% +$218K ﹤0.01% 1008
2022
Q4
$363K Buy
18,181
+3,400
+23% +$65.7K ﹤0.01% 1144
2022
Q3
$318K Sell
14,781
-4,000
-21% -$95.9K ﹤0.01% 1222
2022
Q2
$370K Hold
18,781
﹤0.01% 1198
2022
Q1
$441K Sell
18,781
-5,100
-21% -$118K ﹤0.01% 1293
2021
Q4
$651K Hold
23,881
﹤0.01% 1168
2021
Q3
$658K Hold
23,881
﹤0.01% 1162
2021
Q2
$680K Buy
23,881
+4,500
+23% +$134K ﹤0.01% 1152
2021
Q1
$660K Hold
19,381
﹤0.01% 1041
2020
Q4
$645K Hold
19,381
﹤0.01% 1022
2020
Q3
$623K Buy
19,381
+7,200
+59% +$207K ﹤0.01% 898
2020
Q2
$335K Buy
+12,181
New +$289K ﹤0.01% 1161

Other funds holding INSM

Handelsbanken Fonder's INSM Position: Q2 2026 in Review

Handelsbanken Fonder increased its Insmed (INSM) stake by 181% in Q2 2026, buying an estimated $14.8M and bringing the position to 189,581 shares worth $20.2M. The position accounts for 0.06% of the portfolio, ranked #266.

Handelsbanken Fonder first reported a position in INSM in Q2 2020 and has held it in 25 quarters since. 226 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Handelsbanken Fonder held 189,581 shares of Insmed worth $20.2M as of Q2 2026.
  • Handelsbanken Fonder bought 122,100 Insmed shares in Q2 2026, an estimated $14.8M.
  • Insmed made up 0.06% of Handelsbanken Fonder's portfolio in Q2 2026, its #266 holding.
  • Handelsbanken Fonder first reported a position in Insmed in Q2 2020 and has held it in 25 quarters since.
  • 226 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.